UChicago Medicine

https://www.uchicagomedicine.org/

 

UChicago Medicine
N

Advanced ER+ BC: Novel Endocrine Agents Such as ER PROTACs and ER CERANs With Promising Early Phase Data

By UChicago Medicine FEATURING Nan Chen
By UChicago Medicine FEATURING Nan Chen
88 views
March 4, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
First Annual University of Chicago Multidisciplinary Breast Cancer Symposium
07:49
UChicago Medicine

Antibody Drug Conjugates: Overview and Background of a Revolution in…

Feat. H. Rugo
12:13
UChicago Medicine

Trastuzumab Deruxtecan in HER2+ mBC

Feat. H. Rugo
22:01
UChicago Medicine

2024 Updates on ADCs in HER2-Low, HR+, and TNBC

Feat. H. Rugo
12:49
UChicago Medicine

ADCs in Breast Cancer: Ongoing Trials and Future Directions

Feat. H. Rugo
07:52
UChicago Medicine

New and Emerging CDK4/6i Therapies for Advanced HR+ BC

Feat. N. Chen
09:17
UChicago Medicine

Advanced HR+ BC: Elacestrant vs. ET, Alpelisib/Inavolisib for PIK3CA…

Feat. N. Chen
09:01
UChicago Medicine

Advanced ER+ BC: Novel Endocrine Agents Such as ER PROTACs and ER CE…

Feat. N. Chen
20:56
UChicago Medicine

2024 (Neo)Adjuvant Systemic Therapy Updates for HR+ BC

Feat. G. Fleming
05:59
UChicago Medicine

2024 Neoadjuvant IO Updates for HR+ BC

Feat. G. Fleming
09:59
UChicago Medicine

Neoadjuvant & Adjuvant Therapy for HER2+, High-Risk, Early Stage…

Feat. R. Nanda
17:57
UChicago Medicine

Neoadjuvant & Adjuvant Therapy for High-Risk, Early Stage TNBC

Feat. R. Nanda
04:36
UChicago Medicine

Expert Panel Challenging Case Discussion: 60 y/o Female With a Palpa…

Feat. S. Shubeck, S. Chmura, F. Howard, O. Hahn, S. Hanson